Literature DB >> 25307037

Use of octogenarian donors for liver transplantation: a survival analysis.

D Ghinolfi1, J Marti, P De Simone, Q Lai, D Pezzati, L Coletti, D Tartaglia, G Catalano, G Tincani, P Carrai, D Campani, M Miccoli, G Biancofiore, F Filipponi.   

Abstract

Use of very old donors in liver transplantation (LT) is controversial because advanced donor age is associated with a higher risk for graft dysfunction and worse long-term results, especially for hepatitis C virus (HCV)-positive recipients. This was a retrospective, single-center review of primary, ABO-compatible LT performed between 2001 and 2010. Recipients were stratified in four groups based on donor age (<60 years; 60-69 years; 70-79 years and ≥80 years) and their outcomes were compared. A total of 842 patients were included: 348 (41.3%) with donors <60 years; 176 (20.9%) with donors 60-69 years; 233 (27.7%) with donors 70-79 years and 85 (10.1%) with donors ≥80 years. There was no difference across groups in terms of early (≤30 days) graft loss, and graft survival at 1 and 5 years was 90.5% and 78.6% for grafts <60 years; 88.6% and 81.3% for grafts 60-69 years; 87.6% and 75.1% for grafts 70-79 years and 84.7% and 77.1% for grafts ≥80 years (p = 0.065). In the group ≥80 years, the 5-year graft survival was lower for HCV-positive versus HCV-negative recipients (62.4% vs. 85.6%, p = 0.034). Based on our experience, grafts from donors ≥80 years may provide favorable results but require appropriate selection and allocation policies. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Clinical research/practice; donors and donation: deceased; donors and donation: extended-criteria; liver disease; liver transplantation/hepatology; organ procurement and allocation

Mesh:

Year:  2014        PMID: 25307037     DOI: 10.1111/ajt.12843

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  17 in total

Review 1.  Strategies to optimize the use of marginal donors in liver transplantation.

Authors:  Daniele Pezzati; Davide Ghinolfi; Paolo De Simone; Emanuele Balzano; Franco Filipponi
Journal:  World J Hepatol       Date:  2015-11-18

Review 2.  How important is donor age in liver transplantation?

Authors:  Alberto Lué; Estela Solanas; Pedro Baptista; Sara Lorente; Juan J Araiz; Agustin Garcia-Gil; M Trinidad Serrano
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

3.  Donor age predicts calcineurin inhibitor induced neurotoxicity after liver transplantation.

Authors:  Giovanni Battista Levi Sandri; Valerio Giannelli; Giuseppe Maria Ettorre
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

4.  Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study.

Authors:  Christine E Haugen; Alvin G Thomas; Jacqueline Garonzik-Wang; Allan B Massie; Dorry L Segev
Journal:  Transplantation       Date:  2018-09       Impact factor: 4.939

5.  The corrected donor age for hepatitis C virus-infected liver transplant recipients.

Authors:  Melisa Dirchwolf; Jennifer L Dodge; Jane Gralla; Kiran M Bambha; Trevor Nydam; Kenneth W Hung; Hugo R Rosen; Sandy Feng; Norah A Terrault; Scott W Biggins
Journal:  Liver Transpl       Date:  2015-08       Impact factor: 5.799

6.  Survival benefit of accepting livers from deceased donors over 70 years old.

Authors:  Christine E Haugen; Mary G Bowring; Courtenay M Holscher; Kyle R Jackson; Jacqueline Garonzik-Wang; Andrew M Cameron; Benjamin Philosophe; Mara McAdams-DeMarco; Dorry L Segev
Journal:  Am J Transplant       Date:  2019-01-25       Impact factor: 8.086

7.  Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016.

Authors:  Christine E Haugen; Courtenay M Holscher; Xun Luo; Mary Grace Bowring; Babak J Orandi; Alvin G Thomas; Jacqueline Garonzik-Wang; Allan B Massie; Benjamin Philosophe; Mara McAdams-DeMarco; Dorry L Segev
Journal:  JAMA Surg       Date:  2019-05-01       Impact factor: 14.766

Review 8.  Perfusion machines and hepatocellular carcinoma: a good match between a marginal organ and an advanced disease?

Authors:  Davide Ghinolfi; Erion Rreka; Daniele Pezzati; Franco Filipponi; Paolo De Simone
Journal:  Transl Gastroenterol Hepatol       Date:  2017-11-07

9.  [High donor age for liver transplantation : Tackling organ scarcity in Germany].

Authors:  S Moosburner; P V Ritschl; L Wiering; J M G V Gassner; R Öllinger; J Pratschke; I M Sauer; N Raschzok
Journal:  Chirurg       Date:  2019-09       Impact factor: 0.955

10.  Trends in Outcomes for Marginal Allografts in Liver Transplant.

Authors:  Theodore Zhang; Jordan Dunson; Fasiha Kanwal; Nhu Thao Nguyen Galvan; John M Vierling; Christine O'Mahony; John A Goss; Abbas Rana
Journal:  JAMA Surg       Date:  2020-08-05       Impact factor: 14.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.